Cover Image

A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin®) in Healthy Chinese Males

Abstract Background SCT510 is a recombinant humanized monoclonal antibody targeting vascular endothelial growth factor (VEGF), which is intended as a candidate biosimilar of bevacizumab that is approved for various metastatic cancers.Please confirm change in wording to match definition for VEGF belo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jing Wu (Author), Guolan Wu (Author), Liangzhi Xie (Author), Duo Lv (Author), Chang Xu (Author), Huili Zhou (Author), Lihua Wu (Author), Jingjing Zhang (Author), Jianzhong Shentu (Author)
Format:	Book
Published:	Adis, Springer Healthcare, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetic Properties of Three Forms of Vaginal Progesterone Administered in Either Single Or Multiple Dose Regimen in Healthy Post-menopausal Chinese Women
by: Jianzhong Shentu, et al.
Published: (2017)

A Phase I Comparative Pharmacokinetic and Safety Study of Two Intravenous Formulations of Vinorelbine in Patients With Advanced Non-Small Cell Lung Cancer
by: Guolan Wu, et al.
Published: (2019)

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
by: Kai Huang, et al.
Published: (2021)

Intralesional bevacizumab (Avastin®) as a novel addition to infantile hemangioma management: A medical hypothesis
by: Mohsen Pourazizi, et al.
Published: (2017)

Critical Synthesis Package: Script Concordance Testing (SCT)
by: Javarro Russell
Published: (2013)

5,10-Methylenetetrahydrofolate Reductase Deficiency and Myoclonic Epilepsy
by: J Gordon Millichap, et al.
Published: (2014)

Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double‐blind, parallel‐controlled, phase 1 study
by: Hong Zhang, et al.
Published: (2021)

Development of Learning Model Tools STEAM-based SCT in Wetland Environment Theme
by: Norsalehah Norsalehah, et al.
Published: (2022)

Prevalence of Three-Rooted Mandibular First Molars among Indians Using SCT
by: Amit Kumar Garg, et al.
Published: (2013)

The I510V mutation in KLHL10 in a patient with oligoasthenoteratozoospermia
by: Zicong HUANG, et al.
Published: (2021)

Open-label phase I clinical trial of Ad5-EBOV in Africans in China
by: Lihua Wu, et al.
Published: (2017)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023)

Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth
by: Valerie A. Cruz Flores, et al.
Published: (2021)

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance
by: Qingli Cui, et al.
Published: (2022)

Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev
by: Büşra Gürel, et al.
Published: (2022)

Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial
by: Yongliang Feng, et al.
Published: (2017)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
by: Jingjing Lv, et al.
Published: (2022)

Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study
by: Rong Tang, et al.
Published: (2024)

A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza®) in Healthy Male Subjects
by: Gang Mai, et al.
Published: (2021)

Development and psychometric properties of a Calcium Intake Questionnaire based on the social cognitive theory (CIQ-SCT) for Iranian women
by: Mahin Nematollahi, et al.
Published: (2018)

Keratoacanthoma versus invasive squamous cell carcinoma: a comparison of dermatoscopic vascular features in 510 cases
by: John H. Pyne, et al.
Published: (2014)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ningning Liu, et al.
Published: (2020)

A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx® in Healthy Chinese Male Subjects
by: Yao F, et al.
Published: (2024)

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China
by: Shi-Yuan Wang, et al.
Published: (2017)

Bevacizumab for glioblastoma
by: Narita Y
Published: (2015)

Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin<sup>®</sup> Biosimilar Candidate and Its Innovator: A Comparative Study
by: Busra Gurel, et al.
Published: (2022)

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
by: Abundio Balgos, et al.
Published: (2024)

A aprovação da Resolução CNS nº 510/2016 é um avanço para a ciência brasileira
by: Iara Coelho Zito Guerriero, et al.
Published: (2019)

Assessment of Questionnaire of Physical Activity at Workplace Based on the Social Cognitive Theory (PAWPQ-SCT): A Psychometric Study in Iranian Gas Refinery Workers
by: Kamel Ghobadi, et al.
Published: (2023)

Kaedah pengajaran CHM510: dari sudut pandang pelajar / Sheikh Ahmad Izaddin Sheikh Mohd Ghazali ... [et al.]
by: Sheikh Mohd Ghazali, Sheikh Ahmad Izaddin, et al.
Published: (2021)

Peterson, J. B. (2018). 12 reglas para vivir. Un antídoto al caos. Barcelona: Planeta. 510 pp.
by: Pablo Blanco
Published: (2019)

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
by: Zhi-Wei Wu, et al.
Published: (2023)

Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
by: Dejan B. Budimirovic, et al.
Published: (2021)

Study Concurrent Validity Antara script Consordance Test (SCT dan Multiple Choice Questions (MCQ) dalam Menilai Penalaran Klinik Mahasiswa Kedokteran
by: Yeny Dyah Cahyaningrum, et al.
Published: (2016)

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
by: Di Cao, et al.
Published: (2023)

Bevacizumab-Induced Geographic Tongue
by: Marta Martinez-Garcia, et al.
Published: (2021)

Monitoring antiangiogenesis of bevacizumab in zebrafish
by: Zhang J, et al.
Published: (2018)

Quatramer™ encapsulation of dual‐targeted PI3‐Kδ/HDAC6 inhibitor, HSB‐510, suppresses growth of breast cancer
by: Sachchidanand Tiwari, et al.
Published: (2023)

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial
by: Dandan Zhu, et al.
Published: (2022)

The efficacy of stereotactic radiotherapy followed by bevacizumab and temozolomide in the treatment of recurrent glioblastoma: a case report
by: Wangyan Zhong, et al.
Published: (2024)